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Obesity represents a major public health problem, as it leads 
to metabolic disorders involved in the development of type 
2 diabetes, fatty liver diseases, cardiovascular diseases and 
cancer (1). The Western lifestyle, including over-feeding 
of highly refined diets and sedentary behavior, is associated 
with systemic low-grade inflammation, responsible for 
chronic degenerative disease. Moreover, animal and human 
data have demonstrated the impact of high-fat diet feeding 
on the onset of metabolic endotoxemia. This latter, being 
characterized by increase blood lipopolysaccharide (LPS) 
levels, triggers low-grade inflammation and contributes 
to the development of obesity. The gut microbiota are a 
candidate sources of plasma LPS. Indeed, LPS is a major 
component of the outer membrane in Gram-negative 
bacteria and its plasma levels are correlated with changes in 
intestinal microbiota where the Gram-negative to Gram-
positive ratio is increased by high fat feeding (1).  Not 
surprising that in humans, obesity is characterized by 
dysbiosis, i.e. imbalances in the composition and function of 
the intestinal microbes. Currently, many studies are being 
conducted to assess the contribution of intestinal microflora 
metabolites [mainly short-chain fatty acids (SCFAs)] to the 
organism’s homeostasis. Dietary fibers have been promoted 
for their health benefits and high-fiber intake has been 
reported as beneficial in numerous chronic diseases (2). 
However, we have to keep in mind that consumption of 
dietary fiber significantly alters the composition of the 
gut microbiota. For instance, addition of fibers to the diet 
increases the abundance of butyrate-producing bacteria 
Roseburia species and Eubacterium rectale, whereas a low-
fiber diet is associated to a major decrease in this group, 
with Faecalibacterium prausnitzii becoming the main 
butyrate-producer. Hence, a greater understanding of 
the interaction between dietary fibers and the intestinal 
microbiota could represent a mean of maintaining or 
improving the community of gut microorganisms, 
particularly when dysbiosis exists. In addition, although 
various data indicate that increased SCFAs production 
positively affects the host by exerting antiobesity and 
antidiabetic effects, some in vitro and in vivo studies have 
indicated that overproduction or accumulation of SCFAs 
in the bowel may lead to obesity and cancer development, 
owing to increased energy accumulation and elevation of 
the inflammatory state. As correctly pointed out in the 
recent paper by Wen and Schwabe, more experimental and 
epidemiologic data are needed to completely elucidate the 
link among dietary fibers, gut microbiota and the onset of 
low-grade inflammatory diseases (3). However, the authors 
commented about the recent study by Singh et al. (4) and 
based only on these results stated that soluble fibers could 
be associated to liver disease and hepatocellular carcinoma. 
Specifically, it will be a great achievement to shed light 
on the influence that SCFAs exert on the intestinal 
environment as well as on distal tissues and organs. SCFAs, 
mainly acetate, propionate and butyrate, are organic acid 
produced by intestinal microbial fermentation of dietary 
fibers. Various mechanisms have been highlighted to justify 
the biological effects of butyrate: (I) inhibition of histone 
deacetylase (HDAC); (II) downregulation of neuropilin-1 
(NRP-1); (III) activation of G-protein-coupled receptors, 
GPR41, GPR43 and GPR109A, and of the peroxisome 
proliferator-activated receptor γ (PPARγ); (IV) modulation 
of canonical Wnt signaling pathway; (V) activation of 
AIM2 and NLRP3 inflammasomes, enhancing production 
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of interleukin-18 (IL-18) and epithelial barrier function; 
(VI) differentiation of T lymphocytes into effector (Te) 
and regulatory (T reg) T cells; and (VII) modulation of 
T lymphocytes and dendritic cell functions (5). In the 
meantime, SCFAs can reach the liver through the portal 
vein and directly promote hepatic triglyceride accumulation 
and gluconeogenesis. In addition, various data have 
demonstrated that butyrate appears to have “paradoxical” 
effects on colonic epithelial proliferation due to the fact that 
the response of proliferative cells to butyrate are affected 
by the dose of butyrate, the physiological conditions under 
which the study was performed and the phenotype of the 
target cells (3). Butyrate can instead suppress proliferation 
in hyperproliferation situations (i.e., colon cancers cells), 
or stimulate proliferation in impaired energy status (i.e., 
atrophic colon) or having no effect in normal tissues. 
Similarly, butyrate can promote or inhibit apoptosis (1). 
The concept of prebiotics is based on the possibility 
of favorable modulating the gut microbiota composition 
to maintain and/or promote health, using nutrients such 
as non-digestible, fermentable carbohydrates. Among 
these, the prebiotic effect of inulin-type fructans (ITF) and 
fructo-oligosaccharires (GOS) has been extensively studied 
in vivo, showing a selective stimulation of Bifidobacteria and 
Lactobacilli growth. Moreover, in 4 out of 13 randomized 
controlled trials dietary IFT was positively associated to 
decrease in serum glucose and fasting insulin concentrations. 
These effects were a consequence of the ability of IFT to 
increase the number of endocrine L cells in the jejunum and 
colon, enhancing the production and secretion of glucagon-
like peptide-1 (GLP-1) and reducing glycemia. However, 
a recent meta-analysis of randomized controlled trials has 
shown that modulation of the gut microbiota via prebiotic 
supplementation may present modest effects on body weight 
and waist circumference in obese subjects. Conflicting results 
have been also obtained from cohort-based epidemiological 
studies that aimed at finding a link between fiber intake 
and colorectal cancer prevention (6). On the other hand, 
Donohoe et al using a mouse model demonstrated that 
dietary fiber could protect against colorectal cancer in a 
microbiota- and butyrate-dependent manner (7). In line with 
these data are the results published in a recent paper where 
butyrate was able to significantly abolish the neointimal 
formation in partially ligated carotid arteries of mice 
throughout NLRP3 inflammasome activation (8). 
In conclusion, numerous studied have elucidated the 
complexity of the mechanisms responsible for the effects of 
SCFAs, mainly butyrate. However, more mechanistic and 
clinical studies to entirely clarify the role of dietary fibers 
on human health are needed. 
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